Rituximab-Induced Alopecia Universalis in a Patient With Bullous Pemphigoid
Alopecia areata is a CD8+ T-lymphocyte driven autoimmune disorder leading to reversible hair loss. While most commonly presenting as isolated well-demarcated non-cicatricial alopecic patches on the scalp, subtypes of alopecia areata include alopecia totalis with loss of all scalp hair and alopecia universalis with complete loss of all body hair. Although primarily an idiopathic condition, several …
Alopecia areata is a CD8+ T-lymphocyte driven autoimmune disorder leading to reversible hair loss. While most commonly presenting as isolated well-demarcated non-cicatricial alopecic patches on the scalp, subtypes of alopecia areata include alopecia totalis with loss of all scalp hair and alopecia universalis with complete loss of all body hair. Although primarily an idiopathic condition, several … Continue reading "Rituximab-Induced Alopecia Universalis in a Patient With Bullous Pemphigoid"
Next Steps in Derm, in partnership with Skin of Color Update, interviewed Dr. Shilpi Khetarpal, dermatologist at the Cleveland Clinic. Watch as Dr. Khetarpal outlines the four categories of adjunctive therapies for hair loss and why clinicians should pair them with traditional medical treatments. Learn Dr. Khetarpal’s typical treatment regimen when using PRP in hair loss patients. Find out what … 
Fresh on the heels of the TikTok trend skin cycling is the latest trend hair cycling. While skin cycling is a regimen that rotates between applying skincare products with active ingredients and products with heavy moisturizers, hair cycling is a regimen that rotates between clarifying and hydrating haircare products. Both regimens are intentional routines that incorporate time to rest the skin or … 
INTRODUCTION
Lichen planopilaris (LPP) is a cicatricial alopecia that presents with patchy or diffuse hair loss at the vertex or parietal scalp. Although there is no gold standard therapy, most interventions are immune modulating and aimed at reducing inflammation and terminating the scarring process to prevent further fibrosis.3 Even amongst patients who respond to therapy, hair loss at alopeci … 
Hair loss is making dermatology news in the consumer press after recent news coverage of oral minoxidil. In addition, stories this month address treatments that work for women with thinning hair and answer how much hair is normal to lose.
Get a jumpstart on answering your patients’ questions by knowing what they are reading. Review this list of articles and be ready for your next office visit … 